Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Spironolactone and Changes in Blood Pressure, Heart Rate Variability, and Inflammatory and Cardiac Biomarkers in Hemodialysis Patients With Resistant Hypertension: A Single-Arm Pre-Post Study

NCT07888504 is registered in ClinicalTrials.gov with Universitas Sebelas Maret as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07888504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Spironolactone and Changes in Blood Pressure, Heart Rate Variability, and Inflammatory and Cardiac Biomarkers in Hemodialysis Patients With Resistant Hypertension: A Single-Arm Pre-Post Study
Lead sponsor
Universitas Sebelas Maret
Phase
Phase 4
Overall status
Completed
Start date
August 20, 2024
Completion date
October 31, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, kidney failure, chronic, resistant hypertension

Arms

As registered; 1 arm.

  • Spironolactone 12.5 mg ExperimentalSpironolactone

    Oral spironolactone 12.5 mg once daily for 6 weeks, added to the existing antihypertensive regimen.

Primary endpoints

Registered primary outcome measures; 2 primary.

  • Change in systolic blood pressure Baseline and week 6

    Office systolic blood pressure (mmHg). Change = week-6 value minus baseline value.

  • Change in diastolic blood pressure Baseline and week 6

    Office diastolic blood pressure (mmHg). Change = week-6 value minus baseline value.

Lead sponsor's other trials

Universitas Sebelas Maret, most recent start first.

Similar trials

Same condition (Kidney Failure, Chronic) and phase, most recent start first.